Our policy on harm reduction and e-cigarettes
We support a balanced approach towards nicotine containing products (NCPs) such as e-cigarettes, which maximises their potential to help people quit smoking, whilst minimising the risks of unintended consequences that could promote smoking.
We support ‘light touch’ regulation of new NCPs such as e-cigarettes, to ensure product safety and consistent dose, restrict marketing that risks re-normalising smoking, and stop them being sold to children. At present, we do not believe there is enough evidence to justify an indoor ban on e-cigarettes.
It is important that adequate protections exist to stop the promotion of e-cigarettes to young people and non-smokers. We must also ensure that the tobacco industry’s investment in e-cigarettes does not provide them with an opportunity to influence health policy.
There are a range of unanswered questions about the likely impact of these products on individuals and effective tobacco control policies, which is why we have established the UK E-cigarette Research Forum with Public Health England, and why we are increasing our investment in e-cigarette research.
Q&A: Electronic cigarettes
The marketing of electronic cigarettes in the UK
Cancer Research UK commissioned report on the marketing of electronic cigarettes in the UK, Marisa de Andrade, Gerard Hastings, Kathryn Angus, Diane Dixon and Richard Purves
Cancer Research UK commissioned report on tobacco harm reduction and nicotine containing products: research priorities and policy directions, Marisa de Andrade and Gerard Hastings
Our response to the Welsh Government's Public Health White Paper consultation
Our response to the CAP and BCAP consultation on new advertising rules for e-cigarettes
Get in touch with our policy team to find out more information about our policy on tobacco.
Call our policy team for more information.